4.7 Letter

Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis

Journal

CRITICAL CARE
Volume 25, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s13054-021-03568-8

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available